TRILURON® delivers effective and sustained pain relief with just 3 injections2

reduction in
mean WOMAC pain
subscale scores from
baseline at 6 months
‒­18.4 ± 1.5 mm
(mean ± SE)

reduction in mean
global VAS knee pain
from baseline
‒­ 26.7 mm
(range ‒­30.0 to ‒­23.4)

met the minimum OARSI/OMERACT responder rate for improvement in pain and function

met the MCII Pain responder rate, with 56% meeting the MCII Function responder rate

MCII, minimum clinically important improvement; OARSI, Osteoarthritis Research Society International; OMERACT, outcome measures in rheumatology; VAS, visual analogue scale; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index